1. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2018 Subject(s): Antibodies, Monoclonal -- therapeutic useAsthma -- drug therapyInflammation -- drug therapyAntibodies, Monoclonal -- adverse effectsAntibodies, Monoclonal -- economicsBiological TherapyCost-Benefit AnalysisHypersensitivity -- drug therapyInflammation -- complicationsTreatment OutcomeHumansUnited States
